Orion Biotechnology
PrivateLast Round
Series A
Extension
Mar 15, 2023
Total Funding Raised
$27.02M
Company Overview
Orion Biotechnology is a biotechnology company that develops next-generation therapeutics targeting G Protein-Coupled Receptors (GPCRs) for cancer, obesity, and metabolic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orion Biotechnology Comparables
Compare Orion Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Superluminal Medicines | 84% | |
| Ambrosia Biosciences Inc. | 83% | |
| Confo Therapeutics | 81% | |
Orion Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 15, 2023 | ||||
| Grant | Nov 4, 2021 | ||||
| Series A | Jun 17, 2021 | ||||
| SAFE | Oct 9, 2020 | ||||
| Grant | Jul 30, 2020 | ||||
Grant | Apr 22, 2019 |
Key People
Founding team and executive leadership
Orion Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keiretsu Forum | SAFE, Series A Extension, Series A |
| National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2020
Received funding from National Research Council of Canada Industrial Research Assistance Program.
Orion Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Orion Biotechnology's valuation, stock price, and market status.